{
  "drug_name": "Nadalol",
  "url": "https://wikem.org/wiki/Nadalol",
  "scraped_at": "2026-01-10T07:57:58.392073",
  "sections": {
    "Administration": {
      "text": "Type:\nbeta blocker\nDosage Forms:\nRoutes of Administration: PO\nCommon Trade Names:",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "beta blocker",
          "url": "https://wikem.org/wiki/Beta_blocker"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "40-160mg PO daily",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "",
      "subsections": {
        "Pregnancy_Rating": {
          "text": "C",
          "tables": []
        },
        "Lactation_risk": {
          "text": "Excreted in breastmilk. AAP says compatible with breastfeeding\n[1]",
          "tables": []
        },
        "Renal_Dosing": {
          "text": "CrCl 31-50 mL/min: Give q24-36hr\nCrCl 10-30 mL/min: Give q24-48hr\nCrCl <10 mL/min: Give q40-60hr===Hepatic Dosing===",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Pregnancy_Rating": {
      "text": "C",
      "subsections": {
        "Lactation_risk": {
          "text": "Excreted in breastmilk. AAP says compatible with breastfeeding\n[1]",
          "tables": []
        },
        "Renal_Dosing": {
          "text": "CrCl 31-50 mL/min: Give q24-36hr\nCrCl 10-30 mL/min: Give q24-48hr\nCrCl <10 mL/min: Give q40-60hr===Hepatic Dosing===",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Lactation_risk": {
      "text": "Excreted in breastmilk. AAP says compatible with breastfeeding\n[1]",
      "subsections": {
        "Renal_Dosing": {
          "text": "CrCl 31-50 mL/min: Give q24-36hr\nCrCl 10-30 mL/min: Give q24-48hr\nCrCl <10 mL/min: Give q40-60hr===Hepatic Dosing===",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Renal_Dosing": {
      "text": "CrCl 31-50 mL/min: Give q24-36hr\nCrCl 10-30 mL/min: Give q24-48hr\nCrCl <10 mL/min: Give q40-60hr===Hepatic Dosing===",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Contraindications": {
      "text": "Allergy to class/drug\nOvert cardiac failure, 2°/3° heart block, cardiogenic shock\nAsthma/COPD\nAvoid during breastfeeding\nSinus bradycardia\nSick sinus syndrome without permanent pacemaker\nCaution if:\nNonallergenic bronchospasm\nCerebrovascular insufficiency\nWell-compensated CHF\nDM\nHyperthyroidism/thyrotoxicosis\nLiver disease\nRenal impairment\nPeripheral vascular disease\nPlanned surgery\nPheochromocytoma\nAbrupt cessation may lead to worsened angina and myocardial infarction",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Bronchospasm\nHypotension",
          "tables": []
        },
        "Common": {
          "text": "Drowsiness, insomnia\nDecreased sexual ability\nBradycardia\nDizziness, fatigue\nHypotension\nAbdominal discomfort, constipation, diarrhea, nausea\nCough, nasal congestion\nBronchospasm\nDepression\nDecreased exercise tolerance\nRaynaud's phenomenon\nIncreased triglycerides and insulin resistance, decreased HDL\nMay increase triglyceride levels and insulin resistance, and decrease HDL levels",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Serious": {
      "text": "Bronchospasm\nHypotension",
      "subsections": {
        "Common": {
          "text": "Drowsiness, insomnia\nDecreased sexual ability\nBradycardia\nDizziness, fatigue\nHypotension\nAbdominal discomfort, constipation, diarrhea, nausea\nCough, nasal congestion\nBronchospasm\nDepression\nDecreased exercise tolerance\nRaynaud's phenomenon\nIncreased triglycerides and insulin resistance, decreased HDL\nMay increase triglyceride levels and insulin resistance, and decrease HDL levels",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Common": {
      "text": "Drowsiness, insomnia\nDecreased sexual ability\nBradycardia\nDizziness, fatigue\nHypotension\nAbdominal discomfort, constipation, diarrhea, nausea\nCough, nasal congestion\nBronchospasm\nDepression\nDecreased exercise tolerance\nRaynaud's phenomenon\nIncreased triglycerides and insulin resistance, decreased HDL\nMay increase triglyceride levels and insulin resistance, and decrease HDL levels",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: 10-24h\nMetabolism: none\nExcretion: urine",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Blocks response to beta-adrenergic stimulation to beta1 and beta2 receptors; may reduce portal pressure through beta2 receptor, which reduces portal blood flow",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}